Stock Events

Stock Events

Search...

Regeneron Pharmaceuticals (REGN) Q2 2026 Earnings

30AprConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

8.43

9.92

11.4

12.89

Details

Expected EPS

9.293309

Actual EPS

N/A

Surprise EPS

-9.29

Surprise Percent

+100%

Description

Regeneron Pharmaceuticals (REGN) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.